Results of a phase I clinical trial showed that a new drug targeting mitochondrial function in human cancer cells was safe and showed some efficacy in a heavily pretreated cohort of patients.
Patients with non-small cell lung cancer and resistance to gefitinib do not experience any significant improvement with gefitinib.
Aspirin and other other NSAIDs were associated with a decreased risk for developing an aggressive form of prostate cancer.
Age has in impact on the biology of cancer, treatment goals, and barriers to treatment. Older patients are also currently under-represented in clinical trials, but this need not be the case.
A recent study found no link between bra wearing and increased breast cancer risk among postmenopausal women.
An experimental regimen of once-weekly breast irradiation after lumpectomy provides more convenience to patients at less expense, and results in better completion rates of prescribed radiation treatment.
Is there a good reason to mix nab-paclitaxel (Abraxane) with warm (not cool) normal saline when reconstituting?
Many women under 30 years of age do not recognize the symptoms of cervical cancer.
Screening patients biennially for colorectal cancer increased the rate of diagnosis of high-risk polyps by 89%.
Frank dela Rama, a new member of the Oncology Nurse Advisor editorial board, talks about helping men with newly diagnosed prostate cancer learn about and prepare to cope with their disease.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|